Seung Bin Sung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Seung Bin Sung has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Dongwook Seo
Department of Neurosurgery, Soonchunhyang University Seoul Hospital, College of Medicine, Soonchunhyang University, Seoul, Korea
1 shared publication - Han-Gil Jeong
Department of Neurosurgery, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea
1 shared publication - Hwan Seok Shim
Department of Neurosurgery, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea
1 shared publication - Hyoung Soo Byoun
Department of Neurosurgery, Chungbuk National University Hospital, Cheongju, Republic of Korea
1 shared publication - Hyun Park
Department of Neurosurgery, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea
1 shared publication - Hyunjun Jo
Korea University Guro Hospital
1 shared publication
Latest Publications
- Open Access
- 18 November 2025
- Published by Springer Nature in Neuroradiology
- Vol. 67 (12) , 3439-3448
Comparison between single and dual antiplatelet therapy in patients on oral anticoagulants undergoing coil embolization for unruptured intracranial aneurysms: a retrospective multicenter cohort study
Purpose: The optimal antiplatelet therapy for patients on continuous oral anticoagulants (OACs) who are undergoing coil embolization for unruptured intracranial aneurysms (UIAs) is remains unknown. This study evaluated the efficacy and safety of single- (SAPT) and dual antiplatelet therapy (DAPT) in patients taking OACs who underwent coil embolization for UIAs. Methods: This retrospective multicenter study included patients taking OACs who underwent coil embolization for UIAs at 9 hospitals between January 2016 and August 2023. The primary outcome was a thromboembolic complication within 30 days post-procedure. The secondary outcome was a composite all bleeding events according to the Thrombolysis in Myocardial Infarction bleeding criteria. Results: A total of 112 patients (mean [standard deviation] age, 67.3 [9.7]; 67 females [59.8%]) were included. Among them, 31 patients (27.7%) received SAPT, and 81 patients (72.3%) received DAPT. There was no significant difference in the thromboembolic event rate between the 2 groups (SAPT group: 2 of 31 [6.5%]; DAPT group: 3 of 81 [3.7%]; unadjusted hazard ratio [HR], 0.55 [95% CI, 0.09–3.30]; P = .52). However, the rate of all bleeding events after coil embolization in the DAPT group was significantly higher than that in the SAPT group (SAPT group: 2 of 31 [6.5%]; DAPT group: 22 of 81 [27.2%]; adjusted HR, 5.57 [95% CI, 1.30-23.83]; P = .02). Conclusions: With respect to SAPT, DAPT was not associated with a reduction in thromboembolic complications in patients taking OACs who underwent coil embolization, but it was associated with an increase in all bleeding events.
- 18 November 2025
- Published by Springer Nature in Neuroradiology
- Vol. 67 (12) , 3439-3448
Open AccessComparison between single and dual antiplatelet therapy in patients on oral anticoagulants undergoing coil embolization for unruptured intracranial aneurysms: a retrospective multicenter cohort study
Purpose: The optimal antiplatelet therapy for patients on continuous oral anticoagulants (OACs) who are undergoing coil embolization for unruptured intracranial aneurysms (UIAs) is remains unknown. This study evaluated the efficacy and safety of single- (SAPT) and dual antiplatelet therapy (DAPT) in patients taking OACs who underwent coil embolization for UIAs. Methods: This retrospective multicenter study included patients taking OACs who underwent coil embolization for UIAs at 9 hospitals between January 2016 and August 2023. The primary outcome was a thromboembolic complication within 30 days post-procedure. The secondary outcome was a composite all bleeding events according to the Thrombolysis in Myocardial Infarction bleeding criteria. Results: A total of 112 patients (mean [standard deviation] age, 67.3 [9.7]; 67 females [59.8%]) were included. Among them, 31 patients (27.7%) received SAPT, and 81 patients (72.3%) received DAPT. There was no significant difference in the thromboembolic event rate between the 2 groups (SAPT group: 2 of 31 [6.5%]; DAPT group: 3 of 81 [3.7%]; unadjusted hazard ratio [HR], 0.55 [95% CI, 0.09–3.30]; P = .52). However, the rate of all bleeding events after coil embolization in the DAPT group was significantly higher than that in the SAPT group (SAPT group: 2 of 31 [6.5%]; DAPT group: 22 of 81 [27.2%]; adjusted HR, 5.57 [95% CI, 1.30-23.83]; P = .02). Conclusions: With respect to SAPT, DAPT was not associated with a reduction in thromboembolic complications in patients taking OACs who underwent coil embolization, but it was associated with an increase in all bleeding events.